Calculated low density lipoprotein cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels ≤ 4.52 mmol/l:: An analysis comparing the LipiDirect® magnetic LDL assay with the Friedewald calculation

被引:31
作者
Tighe, DA
Ockene, IS
Reed, G
Nicolosi, R
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA
[3] Univ Massachusetts, Dept Clin Sci, Lowell, MA 01854 USA
关键词
cholesterol; low density lipoprotein; Friedewald formula; direct LDL-C assays; triglycerides;
D O I
10.1016/j.cca.2005.08.026
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Increased low density lipoprotein cholesterol (LDL-C) is an established risk factor for the development of coronary artery disease (CAD). Recent guidelines detail specific LDL-C cutpoints for therapeutic goals. In practice, LDL-C is usually derived from the Friedewald formula (FF). This calculation is known to be inaccurate with serum triglyceride (TG) concentrations > 4.52 mmol/l, however, its accuracy among relatively healthy patient cohorts with TG concentrations <= 4.52 mmol/l is less well studied. Methods: We studied 661 ambulatory adults with TG concentrations <= 4.52 mmol/l and no overt CAD. Fasting venous lipid panels were obtained. LDL-C was calculated from the FF and also directly measured with the LipiDirect (R) Magnetic LDL assay. Linear regression and paired t-test analyses were performed. Results: Calculated and directly measured LDL-C concentrations were significantly different (4.26 +/- 0.88 vs. 4.83 +/- 1.06 mmol/l respectively, p < 0.0001). In 93% of measurements directly measured LDL-C exceeded calculated LDL-C. Although calculated and directly measured LDL-C concentrations were related (R=0.90), the discrepancy between them increased linearly with increasing TG concentrations (R=0.67) and clinically important differences existed at normal or slightly increased TG concentrations. Concordant results for NCEP ATP-III risk categories. were present for only 48.1% of samples. Conclusions: Significant differences between calculated and directly measured LDL-C using the LipiDirect (R) Magnetic LDL assay exist in healthy subjects with TG <= 4.52 mmol/l. These differences are linearly related to TG concentrations and occur frequently at relatively low TG concentrations. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 35 条
[1]   REGRESSION OF CORONARY ATHEROMATOSIS IN RHESUS MONKEYS [J].
ARMSTRONG, ML ;
WARNER, ED ;
CONNOR, WE .
CIRCULATION RESEARCH, 1970, 27 (01) :59-+
[2]  
BACHORIK PS, 1995, CLIN CHEM, V41, P1414
[3]   Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients [J].
Branchi, A ;
Rovellini, A ;
Torri, A ;
Sommariva, D .
DIABETES CARE, 1998, 21 (09) :1397-1402
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[6]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[7]   Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy [J].
Frost, PH ;
Havel, RJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :26B-31B
[8]   Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target [J].
Grundy, SM .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (11) :1379-1380
[9]  
Harris N, 1996, CLIN CHEM, V42, P1182
[10]   A more valid measurement of low-density lipoprotein cholesterol in diabetic patients [J].
Hirany, S ;
Jialal, I .
AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01) :48-53